IP Library Granted Patent US 9,212,352
Granted Patent B2
US 9,212,352 · App. 13/619,099 · Granted Dec 15, 2015

Polypeptides having nucleic acid binding activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,212,352
App. No.
13/619,099
Granted
Dec 15, 2015
Kind
B2
Abstract

Polynucleotides having nucleic acid binding activity are provided. Methods of stabilizing a nucleic acid duplex are provided. Methods of promoting the annealing of complementary nucleic acid strands are provided. Methods of increasing the processivity of a DNA polymerase are provided. Methods of enhancing the activity of a nucleic acid modification enzyme are provided. Fusion proteins are provided. Methods of using fusion proteins are provided. Kits are provided.

Claims (22)

1. A method of increasing the processivity of a DNA polymerase comprising fusing the DNA polymerase to a polypeptide having at least 95% identity to SEQ ID NO:1, wherein the polypeptide has nucleic acid binding activity.

2. A method of increasing the processivity of a DNA polymerase comprising combining a reaction mixture comprising the DNA polymerase with a polypeptide comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the polypeptide has nucleic acid binding activity.

3. The method of claim 1 or 2 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:1 or a fragment of SEQ ID NO:1 that has nucleic acid binding activity.

4. The method of claim 1 , wherein the polypeptide has double-stranded nucleic acid binding activity.

5. The method of claim 1 , wherein the DNA polymerase is thermostable.

6. The method of claim 1 , wherein the polypeptide has a basic isoelectric point.

7. The method of claim 1 , wherein the polypeptide promotes annealing of complementary nucleic acid strands.

8. The method of claim 1 , wherein the DNA polymerase lacks 5′-3′ exonuclease activity.

9. The method of claim 1 , wherein the DNA polymerase is selected from the group consisting of Taq polymerase, Tne polymerase, Tma polymerase, Tfi polymerase, Tth polymerase, and Pfu polymerase.

10. The method of claim 1 , wherein the DNA polymerase and the polypeptide are fused by a linker.

11. The method of claim 1 , wherein the processivity of the DNA polymerase is increased in a primer extension reaction.

12. The method of claim 11 , wherein the primer extension reaction is a polymerase chain reaction (PCR).

13. The method of claim 12 , wherein the PCR is hot start PCR.

14. The method of claim 2 , wherein the polypeptide has double-stranded nucleic acid binding activity.

15. The method of claim 2 , wherein the DNA polymerase is thermostable.

16. The method of claim 2 , wherein the polypeptide has a basic isoelectric point.

17. The method of claim 2 , wherein the polypeptide promotes annealing of complementary nucleic acid strands.

18. The method of claim 2 , wherein the DNA polymerase lacks 5′-3′ exonuclease activity.

19. The method of claim 2 , wherein the DNA polymerase is selected from the group consisting of Taq polymerase, Tne polymerase, Tma polymerase, Tfi polymerase, Tth polymerase, and Pfu polymerase.

20. The method of claim 2 , wherein the processivity of the DNA polymerase is increased in a primer extension reaction.

21. The method of claim 20 , wherein the primer extension reaction is a polymerase chain reaction (PCR).

22. The method of claim 21 , wherein the PCR is hot start PCR.